Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 201–300 of 1,003
Microglia in Parkinson's disease
Ho, M. S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_13 · Cited by 227
Shechter, R., & Schwartz, M. (2013) · The Journal of Pathology · doi:10.1002/path.4106 · Cited by 225
Bollinger, J. L., Bergeon Burns, C. M., & Wellman, C. L. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.003 · Cited by 219
“Neurons constitutively express high levels of CX3CL1, whereas CX3CR1 is found almost exclusively on microglia (Jung et al., 2000; Cardona et al., 2006).”
BackgroundNeuroimmune crosstalk in the central nervous system and its significance for neurological diseases
Tian, L., Ma, L., Kaarela, T., & Li, Z. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-155 · Cited by 221
“Additionally, fractalkine (CX3CL1, neurotactin) is the predominant chemokine expressed and released by neurons in the CNS, whereas its receptor CX3CR1 is primarily expressed in microglia.”
BackgroundInfluentialDonnelly, D. J., Longbrake, E. E., Shawler, T. M., Kigerl, K. A., Lai, W., Tovar, C. A., Ransohoff, R. M., & Popovich, P. G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2114-11.2011 · Cited by 219
“Fractalkine (CX3CL1), a unique chemokine with profound effects on healthy and injured/diseased tissues (Soriano et al., 2002; Lesnik et al., 2003; Nanki et al., 2004; Cardona et al., 2006; Oh et al., 2008), is synthesized as a membrane-spanning adhesion molecule.”
BackgroundMethodSelf-citationWhen and How Do Seizures Kill Neurons, and Is Cell Death Relevant to Epileptogenesis?
Dingledine, R., Varvel, N. H., & Dudek, F. E. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-8914-1_9 · Cited by 219
“Indeed, CX3CR1-defi cient mice exhibit microglia- mediated neurotoxicity, through enhanced IL-1β secretion, after immune challenge [ 14 ].”
BackgroundThe Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S
Clark, A. K., Yip, P. K., & Malcangio, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0828-09.2009 · Cited by 217
“In contrast, in neurodegenerative diseases, the neuronal FKN/microglial CX3CR1 system plays a neuroprotective role aiming to restore tissue functionality, which should therefore be preserved (Cardona et al., 2006).”
BackgroundAlzheimer’s disease as an inflammatory disease
Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216
“CX3CL1 secreted by neurons can bind to its receptor in microglia (CX3CR1), and this process maintains microglia in an ‘off’ state (72), thereby inhibiting the release of inflammatory cytokines (73, 74).”
BackgroundGregory, C. D., & Pound, J. D. (2011) · The Journal of Pathology · doi:10.1002/path.2792 · Cited by 215
Aoyama, T., Inokuchi, S., Brenner, D. A., & Seki, E. (2010) · Hepatology · doi:10.1002/hep.23795 · Cited by 211
Hao, J., Liu, R., Piao, W., Zhou, Q., Vollmer, T. L., Campagnolo, D. I., Xiang, R., La Cava, A., Van Kaer, L., & Shi, F.-D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092749 · Cited by 213
“One study has suggested that microglial neurotoxicity is accelerated by the absence of CX3CR1 (Cardona et al., 2006b).”
BackgroundMethodInfluentialLiu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., Padovani-Claudio, D., He, T., Choi, K., Lane, T. E., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2491 · Cited by 214
“Expression of CXCR2 on microglia cells in freshly isolated brain tissue”
Self-citationThe immunology of neurodegeneration
Czirr, E., & Wyss-Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 213
“Mice that are genetically deficient in CX3CR1 display increased neurotoxicity in response to MPTP, overexpressed mutant SOD, and systemic LPS injections (43).”
Ma, W., Zhao, L., Fontainhas, A. M., Fariss, R. N., & Wong, W. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007945 · Cited by 213
“98%) of the DAPI-positive cells isolated from CX3CR1 transgenic mice were also GFP-positive, indicating the expression of CX3CR1, a specific marker of microglia and dendritic cells in the retina [15] and the brain [35] (Fig.”
BackgroundGu, N., Peng, J., Murugan, M., Wang, X., Eyo, U. B., Sun, D., Ren, Y., DiCicco-Bloom, E., Young, W., Dong, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.018 · Cited by 212
“Future studies are needed to address how CX3CR1 and P2Y12 receptors directly or indirectly regulate microglial proliferation in response to peripheral nerve injury.”
InfluentialInflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. E.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 212
“in the SN following MPTP administration (Cardona et al., 2006).”
BackgroundEvans, T. A., Barkauskas, D. S., Myers, J. T., Hare, E. G., You, J. Q., Ransohoff, R. M., Huang, A. Y., & Silver, J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.013 · Cited by 181
“, 2006), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (Cardona et al., 2006).”
Self-citationModulating neurotoxicity through CX3CL1/CX3CR1 signaling
Limatola, C., & Ransohoff, R. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00229 · Cited by 210
“Cardona et al. (2006) also showed enhanced dopaminergic cell loss in Cx3cr1−/− or Cx3cl1−/− mice after peripheral MPTP administration.”
BackgroundSelf-citationZabel, M. K., Zhao, L., Zhang, Y., Gonzalez, S. R., Ma, W., Wang, X., Fariss, R. N., & Wong, W. T. (2016) · Glia · doi:10.1002/glia.23016 · Cited by 210
“ease outcomes in models of Parkinson’s disease (Cardona et al., 2006), multiple sclerosis (Garcia et al.”
BackgroundEx Vivo Dynamic Imaging of Retinal Microglia Using Time-Lapse Confocal Microscopy
Lee, J. E., Liang, K. J., Fariss, R. N., & Wong, W. T. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2076 · Cited by 207
Self-citationPhagocytic microglia and macrophages in brain injury and repair
Yu, F., Wang, Y., Stetler, A. R., Leak, R. K., Hu, X., & Chen, J. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13899 · Cited by 203
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
Carpanini, S. M., Torvell, M., & Morgan, B. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00362 · Cited by 207
“Compared to tissue macrophages, microglia are relatively “immune suppressed” due to expression of receptors for soluble signals in the extracellular milieu, for example, β2 adrenergic receptor binding of noradrenaline (11, 12), and signals delivered through direct contact with surrounding neurons, including CD200R, CX…”
BackgroundNaert, G., & Rivest, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0299-11.2011 · Cited by 207
“CX3CR1 deficiency is neurotoxic in mouse models of Parkinson’s disease, amyotrophic lateral sclerosis, and systemic lipopolysaccharide administration, suggesting that CX3CL1–CX3CR1 signaling in microglia is beneficial to neurons (Cardona et al., 2006).”
BackgroundTuo, J., Bojanowski, C. M., Zhou, M., Shen, D., Ross, R. J., Rosenberg, K. I., Cameron, D. J., Yin, C., Kowalak, J. A., Zhuang, Z., et al. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0051 · Cited by 205
“In a toxic model of Parkinson disease and a model of genetic motor neuron disease, Cx3cr1 / mice showed more extensive neuronal cell loss than did Cx3cr1 / littermate controls.(58) Activated microglia are associated with AMD.”
BackgroundRegulation of Dynamic Behavior of Retinal Microglia by CX3CR1 Signaling
Liang, K. J., Lee, J. E., Wang, Y. D., Ma, W., Fontainhas, A. M., Fariss, R. N., & Wong, W. T. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3357 · Cited by 204
Self-citationCX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
Subbarayan, M. S., Joly-Amado, A., Bickford, P. C., & Nash, K. R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107989 · Cited by 202
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 203
Bidirectional Microglia‐Neuron Communication in the Healthy Brain
Eyo, U. B., & Wu, L.-J. (2013) · Neural Plasticity · doi:10.1155/2013/456857 · Cited by 202
“Here, we perform a detailed review of neuronal-to-microglial signaling, though we recommend other reviews that have addressed the subject in detail in microglial-neuronal chemokine signaling [5, 6].”
Lyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O’Sullivan, J. B., Smith, A., & Lynch, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06253.x · Cited by 202
“Consistently LPS-triggered microglial activation was demonstrated to be exaggerated in fractalkine receptor-deficient mice compared with wild-type mice providing further evidence of a role for fractalkine in modulating microglial activation (Cardona et al. 2006).”
BackgroundInfluentialEbneter, A., Casson, R. J., Wood, J. P. M., & Chidlow, G. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5284 · Cited by 202
Marchesi, F., Piemonti, L., Fedele, G., Destro, A., Roncalli, M., Albarello, L., Doglioni, C., Anselmo, A., Doni, A., Bianchi, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1810 · Cited by 202
Rustenhoven, J., Aalderink, M., Scotter, E. L., Oldfield, R. L., Bergin, P. S., Mee, E. W., Graham, E. S., Faull, R. L. M., Curtis, M. A., Park, T. I.-H., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0503-0 · Cited by 201
“However, the effects of CX3CL1 are exerted specifically through the fractalkine receptor (CX3CR1) and whilst circulating leukocytes express this receptor [83, 87], in the brain, CX3CR1 expression is limited predominantly to microglia [88].”
Backgroundde Pablos, R. M., Herrera, A. J., Espinosa-Oliva, A. M., Sarmiento, M., Muñoz, M. F., Machado, A., & Venero, J. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-34 · Cited by 201
“Quantification of CD200, CX3CR1 and MCP-1 mRNA expression levels There is evidence that several molecules associate with inhibitory actions on microglia, including CD200 and CX3CR1.”
BackgroundMethodInfluentialM1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
Moehle, M. S., & West, A. B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.018 · Cited by 200
“3) (Cardona et al., 2006; Morganti et al., 2012).”
Corona, A. W., Huang, Y., O'Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., & Godbout, J. P. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-93 · Cited by 200
“injections of LPS (4 daily injections; 20 ug) [10].”
BackgroundHuffman, W. J., Subramaniyan, S., Rodriguiz, R. M., Wetsel, W. C., Grill, W. M., & Terrando, N. (2019) · Brain Stimulation · doi:10.1016/j.brs.2018.10.005 · Cited by 181
“Following endotoxemia, microglia lose their characteristic ramifications and become hypertrophic [36].”
A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain
Romero-Sandoval, A., Chai, N., Nutile-McMenemy, N., & DeLeo, J. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.004 · Cited by 198
“Fractalkine was postulated as a trigger for microglial reactivity (Milligan et al., 2005), but recent studies have shown that fractalkine in fact protects against microglial neurotoxicity (Cardona et al., 2006).”
BackgroundNeuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
Beers, D. R., Zhao, W., Liao, B., Kano, O., Wang, J., Huang, A., Appel, S. H., & Henkel, J. S. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.12.008 · Cited by 198
“Since microglia are the only cells in the CNS to express CX3CR1, and since signaling through CX3CR1 may ameliorate microglial neurotoxicity, we assessed the mRNA expression levels of CX3CR1 in the cervical and lumbar spinal cords of ALS mice; the replacement of microglia by circulating monocytes/macrophages does not t…”
InfluentialThe Role of Microglia in Diabetic Retinopathy
Grigsby, J. G., Cardona, S. M., Pouw, C. E., Muniz, A., Mendiola, A. S., Tsin, A. T. C., Allen, D. M., & Cardona, A. E. (2014) · Journal of Ophthalmology · doi:10.1155/2014/705783 · Cited by 196
“In addition, a deficiency of microglial CX3CR1 induces neurotoxicity and an increase in inflammatory cytokines such as IL-1𝛽, IFN-𝛾, and IL-17 [107, 125].”
BackgroundInfluentialSelf-citationOn phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
“Correspondingly, Cx3cr1-deficient MPs and human Mos are able to induce IL-1b-dependent rod apoptosis in Mo/retina co-cultures (Eandi et al., 2016; Hu et al., 2015).”
BackgroundInfluentialParodi, B., Rossi, S., Morando, S., Cordano, C., Bragoni, A., Motta, C., Usai, C., Wipke, B. T., Scannevin, R. H., Mancardi, G. L., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1422-3 · Cited by 194
“In parallel, the expression of chemokine (C-X3-C motif) receptor 1 (Cx3cr1) and CD200 receptor (Cd200r), receptors essential for the maintenance of interactions with ligands expressed by neurons and whose disruption results in highly activated neurotoxic microglia [8, 61], as well as of that of Nr4a2, an orphan nuclea…”
BackgroundTang, Z., Gan, Y., Liu, Q., Yin, J.-X., Liu, Q., Shi, J., & Shi, F.-D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-26 · Cited by 193
“34vi software (National Institutes of Health) [12].”
BackgroundThe role of microglia in adult hippocampal neurogenesis
Gemma, C., & Bachstetter, A. D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00229 · Cited by 191
“Over the past decade numerous investigators have provided strong support that fractalkine does suppress microglia activation (Cardona et al., 2006; Ransohoff et al., 2007; Bhaskar et al., 2010; Lee et al., 2010).”
CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents
Cipriani, R., Villa, P., Chece, G., Lauro, C., Paladini, A., Micotti, E., Perego, C., De Simoni, M.-G., Fredholm, B. B., Eusebi, F., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3611-11.2011 · Cited by 166
“Moreover, cx3cr1GFP/GFP mice had smaller infarct lesion, less blood– brain barrier damage, and fewer apoptotic cells and infiltrating leukocytes in the ischemic hemisphere, as well as lower expression of the proinflammatory cytokines IL-1 and TNF- (Dènes et al., 2008).”
BackgroundInfluentialMolecular Mechanisms Modulating the Phenotype of Macrophages and Microglia
Amici, S. A., Dong, J., & Guerau-de-Arellano, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01520 · Cited by 191
“The use of irradiated Cx3cr1–green fluorescent protein (GFP) knock-in mice (27, 28) as recipients of WT bone marrow yields a model in which only microglia express GFP and peripheral macrophages can be detected by use of donor markers.”
BackgroundCerebral dysfunctions caused by sepsis during ageing
Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191
Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
Feng, X., Szulzewsky, F., Yerevanian, A., Chen, Z., Heinzmann, D., Rasmussen, R. D., Alvarez-Garcia, V., Kim, Y., Wang, B., Tamagno, I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3730 · Cited by 190
“The effects of CX3CR1 signaling on disease progression vary depending on the type of the CNS disease [18-21].”
BackgroundMethodResultSelf-citationAlleviation of Neurotoxicity by Microglial Human Siglec-11
Wang, Y., & Neumann, H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3940-09.2010 · Cited by 188
“On the other hand, microglia can also express anti-inflammatory cytokines and initiate negative feedback pathways that result in repair, resolution of inflammation, and turning back to tissue homeostasis (Cardona et al., 2006; Neumann et al., 2009; Ransohoff and Perry, 2009).”
BackgroundA review of the mechanisms of cone degeneration in retinitis pigmentosa
Narayan, D. S., Wood, J. P. M., Chidlow, G., & Casson, R. J. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13141 · Cited by 188
“Cx3cr1 is specifically expressed by microglia and, in some disease models, Cx3cr1 deficiency dysregulates microglial activation and promotes neurodegeneration (Cardona et al. 2006; Huang et al. 2006).”
BackgroundEffects of Microglia on Neurogenesis
Sato, K. (2015) · Glia · doi:10.1002/glia.22858 · Cited by 187
“CX3CR1 is expressed primarily in microglia (Cardona et al., 2006; Harrison et al., 1998) and is located in hippocampal neurons (Sheridan and Murphy, 2013).”
BackgroundNeuroimmunological effects of physical exercise in depression
Eyre, H., & Baune, B. T. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.09.015 · Cited by 187
“The mechanism of this suppression is linked to the CD200 glycoprotein and the CX3CR1 receptor which both deliver an inhibitory signal to the microglia (Hoek et al., 2000; Cardona et al., 2006).”
BackgroundTherapeutic approaches to inflammation in neurodegenerative disease
Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 186
Microglia as modulators of cognition and neuropsychiatric disorders
Blank, T., & Prinz, M. (2013) · Glia · doi:10.1002/glia.22372 · Cited by 185
“The function and morphology of microglia is influenced by numerous microenvironmental factors, many of which are produced by neurons (Cardona et al., 2006; Hanisch and Kettenmann, 2007; Lyons et al., 2007).”
BackgroundBrain Inflammation and Microglia: Facts and Misconceptions
Jeong, H.-K., Ji, K., Min, K., & Joe, E.-H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.2.59 · Cited by 184
“Consistent with this, brain inflammation is significantly enhanced in fractalkine receptorknockout mice [23].”
Toll‐like receptor 4 contributes to poor outcome after intracerebral hemorrhage
Sansing, L. H., Harris, T. H., Welsh, F. A., Kasner, S. E., Hunter, C. A., & Kariko, K. (2011) · Annals of Neurology · doi:10.1002/ana.22528 · Cited by 182
Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction
de Haas, A. H., van Weering, H. R. J., de Jong, E. K., Boddeke, H. W. G. M., & Biber, K. P. H. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0036-8 · Cited by 182
“Furthermore, CX3CL1 concentrations higher than 300 pg/mg were described in aqueous extracts of the brain [79], indicating that CX3CL1 can be cleaved from the neuronal membrane and released Table 1 (continued)”
BackgroundNeurotrauma and Inflammation: CNS and PNS Responses
Mietto, B. S., Mostacada, K., & Martinez, A. M. B. (2015) · Mediators of Inflammation · doi:10.1155/2015/251204 · Cited by 181
“Of interest, the lack of CX3CR1 on the macrophage surface exacerbates neuronal loss in models of Parkinson’s disease and amyotrophic lateral sclerosis [55].”
BackgroundMicroglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
Janda, E., Boi, L., & Carta, A. R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00144 · Cited by 180
“In PD models, MPTP-intoxicated mice with CX3CR1 deficiency displayed aggravated pathology and greater loss of tyrosine hydroxilase-immunoreactive (THIR) neurons in the SNc (Cardona et al., 2006).”
Kitazawa, M., Medeiros, R., & M. LaFerla, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315786 · Cited by 178
“CX3CR1, a fractalkine receptor only found in microglia in CNS appears to be important to AD pathology, as crossing CX3CR1 knockout mice with 3xTg-AD mice results in reduced neuronal loss [113, 153].”
BackgroundMicroglial Phenotype and Adaptation
Eggen, B. J. L., Raj, D., Hanisch, U.-K., & Boddeke, H. W. G. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9490-4 · Cited by 179
Reader, B. F., Jarrett, B. L., McKim, D. B., Wohleb, E. S., Godbout, J. P., & Sheridan, J. F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.001 · Cited by 179
“Fractalkine receptor stimulation of brain microglia is anti-inflammatory (Cardona et al., 2006; Corona et al., 2010) and promotes microglial quiescence under homeostatic conditions (Wolf et al., 2013).”
BackgroundDysregulated neuronal–microglial cross-talk during aging, stress and inflammation
Jurgens, H. A., & Johnson, R. W. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.014 · Cited by 179
“The widespread expression of fractalkine by neurons in the CNS along with complementary expression of its receptor on microglia, suggests that fractalkine plays an important physiological role in the communication between neurons and microglia (Cardona et al., 2006; Harrison et al., 1998).”
BackgroundInfluentialThe microglial-motoneuron dialogue in ALS.
Appel, S. H., Zhao, W., Beers, D. R., & Henkel-Tigges, J. (2011) · PubMed Central · Cited by 225
CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice
Fumagalli, S., Perego, C., Ortolano, F., & De Simoni, M. (2013) · Glia · doi:10.1002/glia.22474 · Cited by 178
“…GFP expression under the control of the promoter of cx3cr1 has been widely used to assess microglia behavior in vivo in different models of neurological conditions (Cardona et al., 2006; Cipriani et al., 2011; Corona et al., 2010; Davalos et al., 2005; Donnelly et al., 2011; D enes et al., 2008).”
BackgroundMethodInfluentialRossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 177
Immune system responses in Parkinson's disease: Early and dynamic
Tansey, M. G., & Romero‐Ramos, M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 178
“Indeed, microglia health and homeostasis and the CX3CR1- CX3CL1 axis have been shown to be essential for the protection of neurons against inflammatory stress and toxicity, both local or peripheral (Cardona et al., 2006).”
BackgroundInfluentialSex differences in microglial CX3CR1 signalling determine obesity susceptibility in mice
Dorfman, M. D., Krull, J. E., Douglass, J. D., Fasnacht, R., Lara-Lince, F., Meek, T. H., Shi, X., Damian, V., Nguyen, H. T., Matsen, M. E., et al. (2017) · Nature Communications · doi:10.1038/ncomms14556 · Cited by 175
“Studies of Cx3cr1 gfp/gfp knock-in mice, in which the Cx3cr1 gene has been replaced by Gfp, have revealed that CX3CR1-deficient microglia show excessive cellular activation and overproduction of inflammatory mediators, generally increasing susceptibility to CNS inflammatory diseases 17,23 .”
A Binary Cre Transgenic Approach Dissects Microglia and CNS Border-Associated Macrophages
Kim, J.-S., Kolesnikov, M., Peled-Hajaj, S., Scheyltjens, I., Xia, Y., Trzebanski, S., Haimon, Z., Shemer, A., Lubart, A., Van Hove, H., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.11.007 · Cited by 176
Self-citationInflammation and neurovascular changes in amyotrophic lateral sclerosis
Evans, M. C., Couch, Y., Sibson, N., & Turner, M. R. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 176
“croglia via both fractalkine and CD200 (Cardona et al., 2006; Hoek et al., 2000).”
BackgroundInfluentialProtective effects of microglia in multiple sclerosis
Napoli, I., & Neumann, H. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.024 · Cited by 175
“CX3CR1 deficient mice demonstrated more neuronal cell loss in a toxininduced model of Parkinson disease and in a model of genetic motor neuron disease (Cardona et al., 2006).”
BackgroundHaase, J., & Brown, E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.002 · Cited by 175
Dirscherl, K., Karlstetter, M., Ebert, S., Kraus, D., Hlawatsch, J., Walczak, Y., Moehle, C., Fuchshofer, R., & Langmann, T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-3 · Cited by 172
“They receive permanent tonic inhibitory inputs from neurons to prevent microglial neurotoxicity [8,9].”
From bone marrow to microglia: barriers and avenues
Davoust, N., Vuaillat, C., Androdias, G., & Nataf, S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.01.010 · Cited by 174
Transmembrane chemokines: Versatile ‘special agents’ in vascular inflammation
Weber, C., & Ludwig, A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0035 · Cited by 172
Chemokines and Chemokine Receptors in Neurological Disease: Raise, Retain, or Reduce?
Savarin-Vuaillat, C., & Ransohoff, R. M. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.004 · Cited by 172
Self-citationTickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS
Prinz, M., & Priller, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.015 · Cited by 172
“In the neurotoxin MPTP model of Parkinson's disease, mice deficient in CX3CR1 showed enhanced neurodegeneration and inflammation when compared to wild-type littermates (Cardona et al., 2006).”
InfluentialSelective activation of microglia facilitates synaptic strength
Clark, A. K., Gruber-Schoffnegger, D., Drdla-Schutting, R., Gerhold, K. J., Malcangio, M., & Sandkühler, J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2061-14.2015 · Cited by 171
“Indeed, FKN/CX3CR1 signaling is neuroprotective via ERK and phosphoinositide 3 kinase pathways (Limatola et al., 2005) and inhibition of cytokine release (Cardona et al., 2006).”
BackgroundResultInfluentialMechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications
Khoury, J. E., & Luster, A. D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.08.004 · Cited by 171
Gundersen, V., Storm-Mathisen, J., & Bergersen, L. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00024.2014 · Cited by 171
Staniland, A. A., Clark, A. K., Wodarski, R., Sasso, O., Maione, F., D’Acquisto, F., & Malcangio, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06837.x · Cited by 168
Microglia versus Monocytes: Distinct Roles in Degenerative Diseases of the Retina
Yu, C., Roubeix, C., Sennlaub, F., & Saban, D. R. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.03.012 · Cited by 168
“The increased IL-1β secretion resulting from this dysregulation mediates rod and cone degeneration, and significantly increases CNV [34, 48, 53] (Fig.2A).”
BackgroundInfluentialCNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10
Guldner, I. H., Wang, Q., Yang, L., Golomb, S. M., Zhao, Z., Lopez, J. A., Brunory, A., Howe, E. N., Zhang, Y., Palakurthi, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.064 · Cited by 168
“Cx3cr1 downregulation and its uncoupling from Cx3cl1 allow microglia to mount an inflammatory response, and genetic ablation of Cx3cr1 in mice can improve disease outcome (Cardona et al., 2006).”
BackgroundHypothalamic innate immune reaction in obesity
Kälin, S., Heppner, F. L., Bechmann, I., Prinz, M., Tschöp, M. H., & Yi, C.-X. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.48 · Cited by 167
The role of inflammation in sporadic and familial Parkinson’s disease
Deleidi, M., & Gasser, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1352-y · Cited by 167
“Neuroimmune interactions also modulate DA neuron degeneration, as shown in mouse models of CX3CR1 and CD200R deficiency [23, 50].”
Neuronal CCL21 up‐regulates microglia P2X4 expression and initiates neuropathic pain development
Biber, K., Tsuda, M., Tozaki‐Saitoh, H., Tsukamoto, K., Toyomitsu, E., Masuda, T., Boddeke, H., & Inoue, K. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.89 · Cited by 166
CB2 Receptor in Microglia: The Guardian of Self-Control
Komorowska-Müller, J. A., & Schmöle, A.-C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010019 · Cited by 163
Neuron–Microglia Interactions in Mental Health Disorders: “For Better, and For Worse”
Wohleb, E. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00544 · Cited by 163
“Neuron-derived fractalkine (CX3CL1) regulates microglia activation through binding to CX3CR1, which is enriched on microglia (41).”
BackgroundThe microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
“increased motor neuron loss and decreased lifespan (Cardona et al., 2006).”
BackgroundSystematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders
Stuart, M. J., Singhal, G., & Baune, B. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00357 · Cited by 163
“, 2010), this has also been shown to dysregulate microglial response and increase neurotoxicity following peripheral lipopolysaccharide injections in the CX3CR1 KO mice (Cardona et al., 2006), and decrease neurotoxicity with no harmful effects on microglia in mice models with focal cerebral ischemia (Dénes et al.”
BackgroundPapa, S., Rossi, F., Ferrari, R., Mariani, A., De Paola, M., Caron, I., Fiordaliso, F., Bisighini, C., Sammali, E., Colombo, C., et al. (2013) · ACS Nano · doi:10.1021/nn4036014 · Cited by 159
Mesenchymal Stem Cells Shape Microglia Effector Functions Through the Release of CX3CL1
Giunti, D., Parodi, B., Usai, C., Vergani, L., Casazza, S., Bruzzone, S., Mancardi, G., & Uccelli, A. (2012) · Stem Cells · doi:10.1002/stem.1174 · Cited by 158
Neuro-immune crosstalk in CNS diseases
Kerschensteiner, M., Meinl, E., & Hohlfeld, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.009 · Cited by 179
“Indeed a recent study by Cardona et al. demonstrates that fractalkine is a crucial regulator of inflammatory neurotoxicity in the brain (Cardona et al. 2006) .”
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158
“Impairment of CX3CL1-CX3CR1 results in microglial dysfunction [276].”
BackgroundChemokines and Chemokine Receptors: Multipurpose Players in Neuroinflammation
Ransohoff, R. M., Liu, L., & Cardona, A. E. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82010-1 · Cited by 158
Self-citationLiu, Y., Zeng, X., Hui, Y., Zhu, C., Wu, J., Taylor, D. H., Ji, J., Fan, W., Huang, Z., & Hu, J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.028 · Cited by 158
“For ionized calcium-binding adapter molecule-1 (IBA-1) immunofluorescence (marker for microglia) (Cardona et al., 2006), midbrain sections were treated for DNA denaturation but without H2O2 disposition.”
MethodThe Role of the Immune System in Huntington’s Disease
Ellrichmann, G., Reick, C., Saft, C., & Linker, R. A. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/541259 · Cited by 155
“Notably, brain lysates of R6/2 HD mice display significantly higher levels of IL-1β than wild-type control [23, 74–76].”
BackgroundMicroglia in neuronal plasticity: Influence of stress
Delpech, J.-C., Madore, C., Nadjar, A., Joffre, C., Wohleb, E. S., & Layé, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.034 · Cited by 171
“neurodegenerative disease (Blasko et al., 2004; Cardona et al., 2006).”
BackgroundAdult neurogenesis in Parkinson’s disease
Marxreiter, F., Regensburger, M., & Winkler, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1062-x · Cited by 182
Chemokines in CNS injury and repair
Järve, A., & Müller, H. W. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1427-3 · Cited by 168
“thought to maintain microglia in a resting state, thereby suppressing the neurotoxic and phagocytic activity of these cells in the CNS (Cardona et al. 2006).”
Rasmussen, S., Wang, Y., Kivisäkk, P., Bronson, R. T., Meyer, M., Imitola, J., & Khoury, S. J. (2007) · Brain · doi:10.1093/brain/awm219 · Cited by 154
“These data demonstrate a novel paradigm of cortical and callosal neuropathology in a mouse model of MS, perpetuated by innate immunity.”
Background
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.